Venezuelan Pharmaceutical Company Unipharma to Launch International Headquarters in Tamarac, establishing operations as a new U.S. company, Unipharma, LLC.
Unipharma will use state-of-the-art, proprietary technology to manufacture pharmaceuticals, functional foods and nutraceutical products at its newly renovated facility, bringing 100 jobs to Broward County. These jobs represent an average salary of $49,555 per year (115 percent of the annual average wage in the county). The addition of these pharmaceutical manufacturing jobs to the local economy helped secure Unipharma a total of $500,000 in performance based incentives from the state, county and city through the State of Florida’s Qualified Target Industry tax incentive program over the next seven years. Additionally, the company will make a $50 million capital investment in facilities and equipment between now and 2015.
Unipharma will provide patients and end-consumers with a new delivery system for liquid nutraceutical and pharmaceutical products manufactured with Blow-Fill-Seal technology. This new delivery system will reduce accidental over-the-counter overdoses which are responsible for more than 15,000 annual deaths in the United States alone.
In addition to Greater Fort Lauderdale, other locations under consideration included Madrid, Spain, and Atlanta, Georgia. The company cited connectivity to foreign markets via the port and airport, a growing life sciences cluster and focus on contract manufacturing in the pharmaceutical and neutraceutical industries, as well as the ability to attract top talent due to quality of life as top advantages for relocation to Broward.